Osteoporosis Drugs Market Key Trends and Value Chain Analysis by 2022; Says Merck & Co., Novartis International AG, Amgen Inc.

The Global Osteoporosis Drugs Market which totaled ~ $10,855 million to reach 14,300 million by 2022, growing with a CAGR of 4.7%.

Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.

The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.

The market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.

The market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.

Access Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2479 .

Key Players for Global Osteoporosis Drugs Market:

Some of the key players in this market are: Eli Lilly and Company, Merck & Co., Novartis International AG, Amgen Inc., F. Hoffmann La Roche Ltd., Pfizer Inc., Novo Nordisk, Teva Pharmaceutical Industries Ltd. and others.

Regional Analysis of Global Osteoporosis Drugs Market:

Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.

Brief TOC

1 Introduction

      1.1 Definition
      1.2 Scope of Study
      1.3 Research Objective
      1.4 Assumptions & Limitations
      1.5 Market Structure

2 Research Methodology

      2.1 Research Process
      2.2 Primary Research
      2.3 Secondary Research

Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/2479 .

3 Market Dynamics

      3.1 Drivers
      3.2 Restraints
      3.3 Opportunities
      3.4 Challenges
      3.5 Macroeconomic Indicators

4 Market Factor Analysis

….TOC continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com